Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Dave Gore who wrote (28142)	2/16/2000 10:12:00 AM
From: OFW	Respond to of 150070

SCEP, patent news just out . . . BATON ROUGE, La./FAR HILLS, N.J.--(BUSINESS WIRE)--Feb. 16, 2000--Medisys(R) Technologies, Inc. (SCEP:OTC Bulletin Board), a pioneer in the design and development of safety needle devices, announced today that the Company has received a U.S. patent for its PreSaf(TM) injection safety syringe designed for the significant prefilled syringe market. The patent increases to 19 the number of U.S. patents covering the Company's medical safety devices and other products. PreSaf(TM) is a specialty intramuscular injection safety syringe that provides protection from accidental needlesticks with a passive safety feature that is similar to the Company's other safety products, including its lead product, the CoverTip(TM) hypodermic safety syringe. In comparison to other safety devices, the Medisys safety product line offers the user superior ease of use because the safety feature is engaged automatically. This is a particular benefit for the prefilled syringe market, which supplies medications and vaccines for mass population treatment on a global basis. Prefilled syringes are the preferred method of mass-scale drug delivery for healthcare providers because they lower injection costs by requiring less preparation, fewer materials, and easier storage and disposal. Typical mass-scale applications include influenza and pneumonia prevention injections, and various drugs used in the treatment of AIDS. Medisys(R) President and COO Kerry Frey commented, "The addition of the PreSaf(TM) device complements the Medisys(R) portfolio of patented safety devices and underscores the Company's dedication to safety in the healthcare arena. Our objective is to be a comprehensive source for the healthcare provider who must balance the dual concerns of holding down costs while raising the level of sharps safety." In addition to the CoverTip(TM) hypodermic syringe, previously patented safety devices include: BXDraw(TM), a fine needle biopsy/aspiration safety syringe; SofDraw(TM), a blood and fluid collection safety syringe; and MultiDraw(TM), a needleless multiple vacuum vial blood collection safety device. The Company has filed, or is filing, patent applications for new safety designs in blood collection, capillary blood testing, and tissue excision cutting needles. In total, the Company has 19 patent applications pending for its medical devices in both the U.S. and overseas. Previous press releases can be found on the Company Web site, medisystech.com. Statements in this release may be construed to be forward looking and are made pursuant to the Safe Harbor provisions of the Private Securities Reform Act of 1995. Investors are cautioned that all forward-looking statement involve risks and uncertainties, including, but not limited to, risks associated with regulatory approvals, lack of adequate capitalization and/or other risks inherent in medical device and other product development. --30--ajk/cgo* CONTACT: S/S Small Cap Network Susan Schoch, 212/717-8720